Clinical Trial Update: Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trials assess the safety and efficacy of sublingual immunotherapy tablets for grass pollen–induced allergic rhinoconjunctivitis; results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Grass Pollen Allergy

Drugs mentioned

• Grass pollen SLIT tablet

Snippet

Sponsor: Stallergenes Greer | Conditions: Allergy | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-05-23